Tanl power point
•Download as PPT, PDF•
1 like•705 views
The study aimed to examine respiratory diseases in newborns, especially respiratory distress syndrome (RDS), and the relationship between gestational age, birth weight and RDS. It analyzed 30 newborns admitted to the neonatal intensive care unit and neonatal department from January to February 2008. The findings were that RDS predominantly affects preterm infants under 32 weeks gestation. Treatment for RDS included surfactant therapy, CPAP, ventilation and antibiotics. Combinations and durations of antibiotics depended on the diagnosis and severity of the condition.
Report
Share
Report
Share
![Objectives of the study ,[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
Asthma in pregnancy
asthma in pregnancy is a common medical disorder of great interest, especially with its raising prevalence
Asthma in pregnancy
Asthma during pregnancy differs from non-pregnancy due to immunological, hormonal and respiratory changes. Approximately 1/3 of asthmatic women experience improved symptoms, 1/3 similar symptoms, and 1/3 worse symptoms. Factors like respiratory infections, obesity, and lack of medication adherence can increase risk of exacerbation. Proper asthma management and treatment is important to minimize risks to both mother and fetus.
Asthma in pregnancy
Topics covere
*difference b/w normal and asthmatic bronchi
*Triggering factors
* Respiratory changes during pregnancy
*Effects of asthma on pregnancy
* Pregnancy outcomes
* Clinical features
*Examination
*Management
*Complications
Asthma in Pregnancy
This document discusses asthma in pregnancy. It begins by introducing asthma as a common condition that affects approximately 8% of pregnant women. Left uncontrolled, asthma can increase risks of adverse pregnancy outcomes. The document then covers evaluation and diagnosis of asthma during pregnancy, including physical exams, symptoms, pulmonary function tests, and differentiating normal pregnancy dyspnea. It discusses management of asthma through education, monitoring, and medication including inhaled corticosteroids and beta-agonists. The goal of treatment is prevention of exacerbations to avoid risks to maternal and fetal health.
Asthma in pregnancy
1) Asthma affects approximately 4-8% of pregnant women. While pregnancy does not typically impair lung function, it can intensify the effects of lung diseases like asthma.
2) The pathophysiology of asthma involves chronic airway inflammation from factors like allergens, viruses, and environmental irritants. During pregnancy, changes in lung volumes and capacities can increase a woman's risk of hypoxia from asthma exacerbations.
3) For chronic asthma, treatment focuses on education, environmental control, and pharmacological therapy like inhaled corticosteroids and bronchodilators to maintain lung function. For acute exacerbations, therapy aims to quickly reverse bronchoconstriction and prevent
Asthma in pregnancy
- Asthma is characterized by airway inflammation and constriction caused by various triggers that vary between individuals. Common triggers include allergens, viruses, smoke, and exercise.
- The course of asthma during pregnancy is unpredictable, with symptoms improving in some, worsening in others, and no change in the remaining third. Poorly controlled asthma is associated with increased risks for complications.
- Most asthma medications are considered low risk during pregnancy and breastfeeding. Corticosteroids should not be withheld due to safety concerns. Acute asthma attacks during pregnancy require prompt treatment including oxygen, fluids, bronchodilators, and corticosteroids.
Astma in pregnancy
This document discusses the management of asthma during pregnancy. It notes that asthma is common in pregnancy, with respiratory changes occurring due to anatomical and hormonal factors. Pregnancy can affect asthma severity, with courses varying between women. Well controlled asthma is important for limiting risks to the pregnancy. Treatment follows a stepwise approach, initially using inhaled corticosteroids. Close monitoring is needed to prevent exacerbations while minimizing medication risks for the fetus. Inhaled beta-agonists are generally considered safe options for relief of symptoms during pregnancy.
Asthma in Pregnancy
This document discusses asthma in pregnancy. It defines asthma as a chronic inflammatory disease of the airways characterized by variable airflow limitation and respiratory symptoms. The prevalence of asthma in pregnancy ranges from 1-4%. The document outlines the risks of uncontrolled asthma in pregnancy, including preeclampsia, preterm birth, and low birth weight. It also covers the pathophysiology of asthma and how pregnancy affects respiratory physiology. Examination findings, differential diagnoses, diagnostic tests, treatment options, and management of asthma during pregnancy are discussed in detail.
Recommended
Asthma in pregnancy
asthma in pregnancy is a common medical disorder of great interest, especially with its raising prevalence
Asthma in pregnancy
Asthma during pregnancy differs from non-pregnancy due to immunological, hormonal and respiratory changes. Approximately 1/3 of asthmatic women experience improved symptoms, 1/3 similar symptoms, and 1/3 worse symptoms. Factors like respiratory infections, obesity, and lack of medication adherence can increase risk of exacerbation. Proper asthma management and treatment is important to minimize risks to both mother and fetus.
Asthma in pregnancy
Topics covere
*difference b/w normal and asthmatic bronchi
*Triggering factors
* Respiratory changes during pregnancy
*Effects of asthma on pregnancy
* Pregnancy outcomes
* Clinical features
*Examination
*Management
*Complications
Asthma in Pregnancy
This document discusses asthma in pregnancy. It begins by introducing asthma as a common condition that affects approximately 8% of pregnant women. Left uncontrolled, asthma can increase risks of adverse pregnancy outcomes. The document then covers evaluation and diagnosis of asthma during pregnancy, including physical exams, symptoms, pulmonary function tests, and differentiating normal pregnancy dyspnea. It discusses management of asthma through education, monitoring, and medication including inhaled corticosteroids and beta-agonists. The goal of treatment is prevention of exacerbations to avoid risks to maternal and fetal health.
Asthma in pregnancy
1) Asthma affects approximately 4-8% of pregnant women. While pregnancy does not typically impair lung function, it can intensify the effects of lung diseases like asthma.
2) The pathophysiology of asthma involves chronic airway inflammation from factors like allergens, viruses, and environmental irritants. During pregnancy, changes in lung volumes and capacities can increase a woman's risk of hypoxia from asthma exacerbations.
3) For chronic asthma, treatment focuses on education, environmental control, and pharmacological therapy like inhaled corticosteroids and bronchodilators to maintain lung function. For acute exacerbations, therapy aims to quickly reverse bronchoconstriction and prevent
Asthma in pregnancy
- Asthma is characterized by airway inflammation and constriction caused by various triggers that vary between individuals. Common triggers include allergens, viruses, smoke, and exercise.
- The course of asthma during pregnancy is unpredictable, with symptoms improving in some, worsening in others, and no change in the remaining third. Poorly controlled asthma is associated with increased risks for complications.
- Most asthma medications are considered low risk during pregnancy and breastfeeding. Corticosteroids should not be withheld due to safety concerns. Acute asthma attacks during pregnancy require prompt treatment including oxygen, fluids, bronchodilators, and corticosteroids.
Astma in pregnancy
This document discusses the management of asthma during pregnancy. It notes that asthma is common in pregnancy, with respiratory changes occurring due to anatomical and hormonal factors. Pregnancy can affect asthma severity, with courses varying between women. Well controlled asthma is important for limiting risks to the pregnancy. Treatment follows a stepwise approach, initially using inhaled corticosteroids. Close monitoring is needed to prevent exacerbations while minimizing medication risks for the fetus. Inhaled beta-agonists are generally considered safe options for relief of symptoms during pregnancy.
Asthma in Pregnancy
This document discusses asthma in pregnancy. It defines asthma as a chronic inflammatory disease of the airways characterized by variable airflow limitation and respiratory symptoms. The prevalence of asthma in pregnancy ranges from 1-4%. The document outlines the risks of uncontrolled asthma in pregnancy, including preeclampsia, preterm birth, and low birth weight. It also covers the pathophysiology of asthma and how pregnancy affects respiratory physiology. Examination findings, differential diagnoses, diagnostic tests, treatment options, and management of asthma during pregnancy are discussed in detail.
Treating Asthma in Pregnancy
This document discusses the treatment of asthma during pregnancy. It emphasizes maintaining good asthma control through objective measurement, patient education, and proper medication adherence. Properly controlling asthma reduces risks to both the mother and developing baby. While some medications like inhaled corticosteroids are considered safe in pregnancy, treatment should be individualized and the benefits weighed against any potential risks. The goal is to prevent exacerbations through optimal management.
Asthma in Pregnancy
Asthma, breathing difficulty, pregnancy, shortness of breath, asthma medications, pregnancy, spirometry,
Asthma in pregnancy Dr Muhammad Akram Khan Qaim Khani
This document discusses asthma in pregnancy. It begins by defining asthma according to the WHO. It then discusses the pathophysiology of asthma and how pregnancy affects the respiratory system. It describes how to assess and monitor asthma severity using peak flow meters and spirometry. The document outlines different medication options for treating asthma during pregnancy, including quick relief medications like beta-agonists and long term control medications like inhaled corticosteroids. It discusses factors that influence asthma control and complications that can arise if asthma is not well-controlled during pregnancy.
Asthma in pregnancy
This document discusses asthma management during pregnancy. It begins by describing how pregnancy can affect asthma severity, noting that prior asthma severity predicts severity during pregnancy. It then explains how asthma can impact pregnancy outcomes like preterm delivery. The rest of the document covers general asthma care during pregnancy, including monitoring, education, trigger avoidance, and medications. It notes most asthma medications are category B or C but are generally considered safe in pregnancy with monitoring. Inhaled short-acting beta agonists are recommended for acute exacerbations. The goal is preventing acute episodes and optimizing lung function to reduce risks.
Asthma in Pregnancy
This summary reviews several studies on how asthma is affected during pregnancy. The studies show rates of asthma worsening from 14-41% of patients, unchanged in 26-43%, and
Bronchial asthama and pregnancys
This document discusses asthma, including its pathogenesis, triggers, symptoms, diagnosis and classification. It notes that asthma is a chronic inflammatory airway disease characterized by reversible bronchial constriction in response to multiple stimuli. Common symptoms include dyspnea, cough and wheezing. Diagnosis involves assessing symptoms, demonstrating reversibility of airflow obstruction via spirometry, and ruling out alternative diagnoses. Asthma is classified based on severity of symptoms and lung function.
Case Study On Asthma
Viral respiratory infections are a common trigger for acute asthma episodes. Viruses like rhinovirus can damage the airway and impair its defenses, making it more susceptible to inflammation. Early life wheezing from viruses is a risk factor for developing asthma. The sympathetic nervous system response to asthma involves adrenaline release and bronchodilation, but fails to fully reverse bronchoconstriction. James' symptoms relate to this sympathetic response. Salbutamol acts as a sympathomimetic drug by directly stimulating beta-2 receptors, mimicking the effects of adrenaline to induce bronchodilation. It was administered to James to help reverse bronchoconstriction from the asthma episode.
Presentation on pathogen of meningitis.siam (ppt file)
Meningitis is an inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It can be caused by various pathogens like bacteria and viruses. Common symptoms include high fever, headache, and neck stiffness. Treatment involves prompt administration of antibiotics depending on the causative organism. Prevention strategies include vaccination and avoiding sharing personal items that may spread pathogens.
2 genetic susceptibility to bronchial asthma
This lecture has been presented by DR.Hajer moaweia / Abusetta chest center in Global asthma day 2018.
Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...
Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...amir mohammad Armanian
This study assessed the effects of aminophylline in reducing chronic lung disease (CLD) in very premature infants. 52 infants weighing 1200g or less were randomly assigned to receive aminophylline for the first 10 days (group A) or no aminophylline (group C). Infants receiving aminophylline had significantly shorter oxygen dependency times and lower incidence of CLD compared to the control group. Only 2 infants who received aminophylline developed CLD, compared to 11 infants in the control group. No side effects were reported from aminophylline. This study supports the preventative effects of aminophylline in reducing CLD in very premature infants.Asthma management phenotype based approach
Phenotypes and endotypes are approaches to classifying asthma subtypes based on clinical characteristics and underlying biological mechanisms. The document discusses several potential asthma endotypes including:
1) TH2-high endotypes like early-onset allergic asthma characterized by genetics predisposing to TH2 cytokines, biomarkers like elevated IgE and eosinophils, and response to anti-IgE therapy.
2) Late-onset eosinophilic asthma characterized by persistent sputum eosinophilia despite steroids and potential response to anti-IL5 therapy.
3) Aspirin-exacerbated respiratory disease which may be a similar endotype to intrinsic or allergic asthma due to acquired NSA
Respiratory distress syndrome
Respiratory Distress Syndrome (RDS) is a condition seen primarily in premature infants caused by a lack of pulmonary surfactant. This deficiency leads to alveolar collapse and respiratory failure. The risk of developing RDS increases the younger the gestational age. Clinical presentation includes tachypnea, retractions, and hypoxemia. Diagnosis is made based on clinical features and chest x-ray showing diffuse lung opacities. Treatment focuses on supportive care including oxygen therapy and mechanical ventilation. Surfactant replacement therapy is also used to reduce mortality from RDS.
Surfactants
Surfactants are substances that can reduce the surface tension of liquids and allow them to foam or penetrate solids. They are used to help chemicals work together, such as allowing water to release oils from clothing during laundry. In embalming, a surfactant called Water/Clot Guard is added to condition water and aid the penetration of embalming chemicals into tissues by understanding how water molecules interact with other chemicals and capillaries. While surfactants are almost always useful in embalming solutions, knowing when to use them comes with experience.
Respiratory distress syndrome in neonates
This document discusses respiratory distress syndrome (RDS), also known as hyaline membrane disease (HMD). RDS is caused by surfactant deficiency in preterm infants and affects lung development and function. Key points include:
- RDS incidence is inversely related to gestational age and birth weight, peaking at 24-48 hours of life.
- Surfactant deficiency leads to atelectasis, decreased lung compliance, increased work of breathing and hypoxemia.
- Surfactant is normally produced by type II alveolar cells starting around 24 weeks gestation and is essential for reducing surface tension in the lungs.
Surfactant therapy
This document discusses rational surfactant therapy. It begins by establishing that surfactant replacement therapy works based on multiple randomized controlled trials showing reductions in mortality, duration of ventilation and hospital stay. It describes the types of surfactants available and recommends natural surfactants. The document discusses the timing of surfactant replacement, benefits of multiple doses, and synergistic effects with antenatal steroids. Ventilatory management after surfactant including INSURE technique is covered, along with risks of the therapy.
Surface active agents
This document presents a summary of surfactants by Pradeepkumar Yadav and Ramniranjan Jhunjunwala from MSC(II) (Physical Chemistry) at an unspecified college. It defines surfactants as amphiphilic molecules that absorb at interfaces and have both hydrophilic and hydrophobic regions. The document outlines the critical micelle concentration and micellar solubilization. It describes different types of surfactants and some of their properties and applications including wetting, emulsification, foaming, and use in pharmaceuticals.
Surfactants
The document defines surfactants as substances that decrease surface tension by absorbing to surfaces/interfaces. Surfactants have a hydrophilic group that attracts water and a hydrophobic group that repels water. This amphipathic structure allows surfactants to position at water-organic interfaces. Surfactants are classified as ionic (anionic, cationic), nonionic, or amphoteric depending on their head groups. Key properties include critical micelle concentration (CMC) and hydrophile-lipophile balance (HLB). Surfactants have many applications including detergents, personal care products, paints, food processing, and mining.
Respiratory Distress Syndrome (Rds)
Respiratory distress syndrome (RDS), also known as hyaline membrane disease (HMD), is an acute lung disease in newborns caused by pulmonary surfactant deficiency, which tends to occur in preterm infants younger than 32 weeks gestational age. The incidence increases with lower gestational age and higher rates are seen in infants of diabetic mothers. Treatment involves oxygen therapy, ventilation support, and replacement of pulmonary surfactant to reduce mortality and complications like pneumothorax. Prevention strategies include antenatal corticosteroid therapy and prophylactic surfactant treatment.
Surfactant
This document discusses pulmonary surfactant, which lines the alveoli and reduces surface tension. Surfactant deficiency causes respiratory distress syndrome (RDS) in preterm infants by increasing surface tension. Surfactant contains lipids like phosphatidylcholine and proteins important for function. Natural animal-derived surfactants are superior to older synthetic surfactants without proteins. A synthetic surfactant containing a protein analogue was as effective as natural surfactants in clinical trials. Prophylactic or early surfactant treatment within 2 hours of birth reduces mortality and morbidity compared to rescue treatment after RDS onset in infants under 30 weeks.
Taquipnea transitoria del recién nacido: Que hay de nuevo?
Taquipnea transitoria del recién nacido: Que hay de nuevo?
Transient tachypnea of the newborn: What's new?
Pneumonia in children
This clinical guideline provides recommendations for diagnosing and treating pneumonia in children. Pneumonia is common in children under 2 years old and can be caused by bacteria, viruses, or mixed infections depending on the child's age. Clinical features like fever, cough, difficulty breathing, and fast breathing should prompt consideration of pneumonia. Chest x-rays are not needed for most cases but can help in complicated cases. Most children can be treated with oral antibiotics at home, while those with more severe symptoms require hospital admission and intravenous antibiotics. Complications like lung abscesses may occur and require longer treatment and follow up to ensure full recovery. Recurrent pneumonia may indicate underlying conditions that require further investigation.
Asthma and pregnancy
incidence and prevalence of asthma in pregnancy, guidelines for diagnosis and management of during pregnancy. drugs to be given and drugs to be avoided during pregnancy. pregnancy outcome in asthma patients.
More Related Content
What's hot
Treating Asthma in Pregnancy
This document discusses the treatment of asthma during pregnancy. It emphasizes maintaining good asthma control through objective measurement, patient education, and proper medication adherence. Properly controlling asthma reduces risks to both the mother and developing baby. While some medications like inhaled corticosteroids are considered safe in pregnancy, treatment should be individualized and the benefits weighed against any potential risks. The goal is to prevent exacerbations through optimal management.
Asthma in Pregnancy
Asthma, breathing difficulty, pregnancy, shortness of breath, asthma medications, pregnancy, spirometry,
Asthma in pregnancy Dr Muhammad Akram Khan Qaim Khani
This document discusses asthma in pregnancy. It begins by defining asthma according to the WHO. It then discusses the pathophysiology of asthma and how pregnancy affects the respiratory system. It describes how to assess and monitor asthma severity using peak flow meters and spirometry. The document outlines different medication options for treating asthma during pregnancy, including quick relief medications like beta-agonists and long term control medications like inhaled corticosteroids. It discusses factors that influence asthma control and complications that can arise if asthma is not well-controlled during pregnancy.
Asthma in pregnancy
This document discusses asthma management during pregnancy. It begins by describing how pregnancy can affect asthma severity, noting that prior asthma severity predicts severity during pregnancy. It then explains how asthma can impact pregnancy outcomes like preterm delivery. The rest of the document covers general asthma care during pregnancy, including monitoring, education, trigger avoidance, and medications. It notes most asthma medications are category B or C but are generally considered safe in pregnancy with monitoring. Inhaled short-acting beta agonists are recommended for acute exacerbations. The goal is preventing acute episodes and optimizing lung function to reduce risks.
Asthma in Pregnancy
This summary reviews several studies on how asthma is affected during pregnancy. The studies show rates of asthma worsening from 14-41% of patients, unchanged in 26-43%, and
Bronchial asthama and pregnancys
This document discusses asthma, including its pathogenesis, triggers, symptoms, diagnosis and classification. It notes that asthma is a chronic inflammatory airway disease characterized by reversible bronchial constriction in response to multiple stimuli. Common symptoms include dyspnea, cough and wheezing. Diagnosis involves assessing symptoms, demonstrating reversibility of airflow obstruction via spirometry, and ruling out alternative diagnoses. Asthma is classified based on severity of symptoms and lung function.
Case Study On Asthma
Viral respiratory infections are a common trigger for acute asthma episodes. Viruses like rhinovirus can damage the airway and impair its defenses, making it more susceptible to inflammation. Early life wheezing from viruses is a risk factor for developing asthma. The sympathetic nervous system response to asthma involves adrenaline release and bronchodilation, but fails to fully reverse bronchoconstriction. James' symptoms relate to this sympathetic response. Salbutamol acts as a sympathomimetic drug by directly stimulating beta-2 receptors, mimicking the effects of adrenaline to induce bronchodilation. It was administered to James to help reverse bronchoconstriction from the asthma episode.
Presentation on pathogen of meningitis.siam (ppt file)
Meningitis is an inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It can be caused by various pathogens like bacteria and viruses. Common symptoms include high fever, headache, and neck stiffness. Treatment involves prompt administration of antibiotics depending on the causative organism. Prevention strategies include vaccination and avoiding sharing personal items that may spread pathogens.
2 genetic susceptibility to bronchial asthma
This lecture has been presented by DR.Hajer moaweia / Abusetta chest center in Global asthma day 2018.
Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...
Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...amir mohammad Armanian
This study assessed the effects of aminophylline in reducing chronic lung disease (CLD) in very premature infants. 52 infants weighing 1200g or less were randomly assigned to receive aminophylline for the first 10 days (group A) or no aminophylline (group C). Infants receiving aminophylline had significantly shorter oxygen dependency times and lower incidence of CLD compared to the control group. Only 2 infants who received aminophylline developed CLD, compared to 11 infants in the control group. No side effects were reported from aminophylline. This study supports the preventative effects of aminophylline in reducing CLD in very premature infants.Asthma management phenotype based approach
Phenotypes and endotypes are approaches to classifying asthma subtypes based on clinical characteristics and underlying biological mechanisms. The document discusses several potential asthma endotypes including:
1) TH2-high endotypes like early-onset allergic asthma characterized by genetics predisposing to TH2 cytokines, biomarkers like elevated IgE and eosinophils, and response to anti-IgE therapy.
2) Late-onset eosinophilic asthma characterized by persistent sputum eosinophilia despite steroids and potential response to anti-IL5 therapy.
3) Aspirin-exacerbated respiratory disease which may be a similar endotype to intrinsic or allergic asthma due to acquired NSA
What's hot (11)
Asthma in pregnancy Dr Muhammad Akram Khan Qaim Khani
Asthma in pregnancy Dr Muhammad Akram Khan Qaim Khani
Presentation on pathogen of meningitis.siam (ppt file)
Presentation on pathogen of meningitis.siam (ppt file)
Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...
Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...
Viewers also liked
Respiratory distress syndrome
Respiratory Distress Syndrome (RDS) is a condition seen primarily in premature infants caused by a lack of pulmonary surfactant. This deficiency leads to alveolar collapse and respiratory failure. The risk of developing RDS increases the younger the gestational age. Clinical presentation includes tachypnea, retractions, and hypoxemia. Diagnosis is made based on clinical features and chest x-ray showing diffuse lung opacities. Treatment focuses on supportive care including oxygen therapy and mechanical ventilation. Surfactant replacement therapy is also used to reduce mortality from RDS.
Surfactants
Surfactants are substances that can reduce the surface tension of liquids and allow them to foam or penetrate solids. They are used to help chemicals work together, such as allowing water to release oils from clothing during laundry. In embalming, a surfactant called Water/Clot Guard is added to condition water and aid the penetration of embalming chemicals into tissues by understanding how water molecules interact with other chemicals and capillaries. While surfactants are almost always useful in embalming solutions, knowing when to use them comes with experience.
Respiratory distress syndrome in neonates
This document discusses respiratory distress syndrome (RDS), also known as hyaline membrane disease (HMD). RDS is caused by surfactant deficiency in preterm infants and affects lung development and function. Key points include:
- RDS incidence is inversely related to gestational age and birth weight, peaking at 24-48 hours of life.
- Surfactant deficiency leads to atelectasis, decreased lung compliance, increased work of breathing and hypoxemia.
- Surfactant is normally produced by type II alveolar cells starting around 24 weeks gestation and is essential for reducing surface tension in the lungs.
Surfactant therapy
This document discusses rational surfactant therapy. It begins by establishing that surfactant replacement therapy works based on multiple randomized controlled trials showing reductions in mortality, duration of ventilation and hospital stay. It describes the types of surfactants available and recommends natural surfactants. The document discusses the timing of surfactant replacement, benefits of multiple doses, and synergistic effects with antenatal steroids. Ventilatory management after surfactant including INSURE technique is covered, along with risks of the therapy.
Surface active agents
This document presents a summary of surfactants by Pradeepkumar Yadav and Ramniranjan Jhunjunwala from MSC(II) (Physical Chemistry) at an unspecified college. It defines surfactants as amphiphilic molecules that absorb at interfaces and have both hydrophilic and hydrophobic regions. The document outlines the critical micelle concentration and micellar solubilization. It describes different types of surfactants and some of their properties and applications including wetting, emulsification, foaming, and use in pharmaceuticals.
Surfactants
The document defines surfactants as substances that decrease surface tension by absorbing to surfaces/interfaces. Surfactants have a hydrophilic group that attracts water and a hydrophobic group that repels water. This amphipathic structure allows surfactants to position at water-organic interfaces. Surfactants are classified as ionic (anionic, cationic), nonionic, or amphoteric depending on their head groups. Key properties include critical micelle concentration (CMC) and hydrophile-lipophile balance (HLB). Surfactants have many applications including detergents, personal care products, paints, food processing, and mining.
Respiratory Distress Syndrome (Rds)
Respiratory distress syndrome (RDS), also known as hyaline membrane disease (HMD), is an acute lung disease in newborns caused by pulmonary surfactant deficiency, which tends to occur in preterm infants younger than 32 weeks gestational age. The incidence increases with lower gestational age and higher rates are seen in infants of diabetic mothers. Treatment involves oxygen therapy, ventilation support, and replacement of pulmonary surfactant to reduce mortality and complications like pneumothorax. Prevention strategies include antenatal corticosteroid therapy and prophylactic surfactant treatment.
Surfactant
This document discusses pulmonary surfactant, which lines the alveoli and reduces surface tension. Surfactant deficiency causes respiratory distress syndrome (RDS) in preterm infants by increasing surface tension. Surfactant contains lipids like phosphatidylcholine and proteins important for function. Natural animal-derived surfactants are superior to older synthetic surfactants without proteins. A synthetic surfactant containing a protein analogue was as effective as natural surfactants in clinical trials. Prophylactic or early surfactant treatment within 2 hours of birth reduces mortality and morbidity compared to rescue treatment after RDS onset in infants under 30 weeks.
Viewers also liked (8)
Similar to Tanl power point
Taquipnea transitoria del recién nacido: Que hay de nuevo?
Taquipnea transitoria del recién nacido: Que hay de nuevo?
Transient tachypnea of the newborn: What's new?
Pneumonia in children
This clinical guideline provides recommendations for diagnosing and treating pneumonia in children. Pneumonia is common in children under 2 years old and can be caused by bacteria, viruses, or mixed infections depending on the child's age. Clinical features like fever, cough, difficulty breathing, and fast breathing should prompt consideration of pneumonia. Chest x-rays are not needed for most cases but can help in complicated cases. Most children can be treated with oral antibiotics at home, while those with more severe symptoms require hospital admission and intravenous antibiotics. Complications like lung abscesses may occur and require longer treatment and follow up to ensure full recovery. Recurrent pneumonia may indicate underlying conditions that require further investigation.
Asthma and pregnancy
incidence and prevalence of asthma in pregnancy, guidelines for diagnosis and management of during pregnancy. drugs to be given and drugs to be avoided during pregnancy. pregnancy outcome in asthma patients.
Op RDS
This document discusses infant respiratory distress syndrome (IRDS), including its causes, signs and symptoms, diagnostic evaluation, treatment and nursing management. IRDS is caused by a lack of surfactant in premature infants' lungs. It can cause respiratory distress seen as tachypnea, retractions and grunting. Diagnosis involves blood tests and chest x-rays showing atelectasis. Treatment includes oxygen therapy, surfactant replacement, ventilation support and ensuring temperature and nutrition. Nursing care focuses on monitoring breathing and oxygen levels, preventing hypothermia and infection, and supporting nutrition and developmental care.
management of neonatal sepsis
This document discusses the management of neonatal sepsis and identifies areas of potential malpractice. It presents two case studies of neonates with sepsis that were potentially mismanaged. The document then outlines key topics to be covered, including features of neonatal sepsis, the role of CRP and procalcitonin in diagnosis, treatment planning considerations, controversies around certain drug uses, the role of blood exchange transfusions, and potential adjuvant therapies. Overall, the document aims to improve management of neonatal sepsis by revising basic knowledge around appropriate diagnosis and treatment.
Respiratory disorders in pregnancy
The document discusses the physiological changes that occur in the respiratory system during pregnancy. There is an increase in minute ventilation leading to respiratory alkalosis. Functional residual capacity decreases while vital capacity remains unchanged. Shortness of breath is common during pregnancy. Common respiratory conditions complicating pregnancy include asthma, tuberculosis, pneumonia, and influenza. Treatment for these conditions is largely similar to non-pregnant patients with some modifications due to safety.
Pregnancy in Dermatomyositis Complicated with Covid
Pregnancy in Dermatomyositis Complicated with CovidInternational Journal of Medical and Pharmaceutical Research
32-year-oldprimigravida, CATB2, Covid positive patient with acute onset of facial palsy, fever, sore throat and productive cough referred from a peripheral hospital came for caesarian section. Past history revealed occurrence of juvenile dermatomyositis for which she took steroids for one and a half year which was slowly weaned off. Prevalence of dermatomyositis is 1to 8 in 100,000. She was started on steroids which was to be continued for a week after caesarian section. She was on paracetamol and cefuroxime on admission. Basic investigations were normal. Caesarian section was done in covid theater following covid protocols under subarachnoid anesthesia Baby had an APGAR score of 9 and was covid negative. Mothers’ recovery was slow. Facial deviation got corrected in 4to 5 months. Ptosis persisted even after 9months and is on treatment. Dermatomyositis is an uncommon inflammatory disease that affects mainly proximal muscle limiting day to day activities. But it can affect respiratory, cardiac and gastrointestinal systems, eyes and joints. Diagnosis is by muscle biopsy and an increase in muscle enzymes. Pregnancy during remission period is safe. But pregnancy can provoke the disease. Skin changes usually precedes muscle symptoms, though we could not notify any lesions. Lung involvement is prominent, and covid also carries the same amount of risk with respiratory system. Systemic glucocorticoids are the first line of treatment. Immunosuppressant drugs Azathioprine and methotrexate are added as second line of therapy, though these drugs are unsafe during pregnancy. Intravenous immunoglobulin, give good outcome during pregnancy. Plasmapheresis is also beneficial. Most of the pregnant patients end up in caesariansection. Regionalanesthesia is the choice of anesthesia. Covid patients with respiratory infections, maintaining saturation above90%, choice of anesthesia is usually regional anesthesia.
Key Words: Juvenile Dermatomyositis, COVID, Cesarian Section
Respiratory distress in neonates
the common type of respiratory distress in newborn. To be in paeds, we have to understand these properly.
I tried my best to make proper presentation.
MANAGEMENT OF PRETERM LABOUR:ATOSIBAN
On December 25, 1642 a widow gave birth prematurely to a small baby boy who could fit in a quart mug. This baby survived and grew up to be Sir Isaac Newton, providing one of the earliest descriptions of preterm birth. Preterm birth, defined as birth between 28-36+6 weeks gestation, accounts for 5-10% of births and is a leading cause of perinatal morbidity and mortality. Multiple pathological processes can lead to preterm parturition, including ascending intrauterine infections. Tocolytic drugs are used to suppress uterine contractions and delay preterm delivery to allow for corticosteroid administration and transfer to facilities with neonatal intensive care. However, currently available tocolytics have poor
falla respiratoria.pdf
This review discusses acute respiratory failure in children. It aims to describe the physiologic peculiarities that make children more vulnerable to respiratory failure compared to adults. Some key points:
1) Acute respiratory failure is common in pediatric intensive care units and is usually caused by lung disease, airway disease, or inadequate respiratory effort.
2) Infant respiratory physiology increases susceptibility due to higher metabolism, immature breathing control, and more collapsible/compliant airways compared to adults.
3) Early recognition of respiratory failure is important through history and physical exam to identify the underlying cause and guide life-saving interventions before cardiopulmonary arrest occurs.
Respiratory Disorders In Pregnancy 26092023.pptx
This document discusses respiratory disorders that can occur during pregnancy. It begins by outlining the normal physiological changes to respiration that occur during pregnancy, including increased oxygen demand and changes in lung volume. It then examines specific pulmonary diseases like asthma, tuberculosis, influenza, and COVID-19 that can impact pregnant women. For each condition, it describes associated risks, symptoms, diagnosis, effects on pregnancy, and recommended treatment approaches. The goal is to understand how these respiratory disorders present during pregnancy and should be managed while considering the health and safety of both the mother and fetus.
Bronchopulmonary dysplasia updates_and_prevention dr falakha
The document discusses bronchopulmonary dysplasia (BPD) and strategies for prevention. It notes that BPD results from disrupted alveolar development and remodeling of the airways, vasculature, and smooth muscle. Risk factors include prematurity, genetics, chorioamnionitis, and exposures associated with resuscitation and mechanical ventilation. Strategies discussed to prevent BPD include using lower oxygen concentrations during resuscitation, applying continuous positive airway pressure, and avoiding overinflation and atelectrauma through gentle ventilation techniques. Future research is still needed to develop more evidence-based prevention and treatment approaches for BPD.
RDS-.pptx
Respiratory distress is common in preterm infants and can have serious consequences. It is defined as the presence of tachypnea, retractions, or grunting. Common causes include respiratory distress syndrome (RDS) due to surfactant deficiency. Assessment involves evaluating respiratory rate, work of breathing, oxygen needs and chest x-ray findings. Management consists of supportive care including oxygen supplementation, monitoring, antibiotics if indicated. Surfactant replacement therapy improves outcomes in RDS but can increase risk of apnea. Non-invasive respiratory support with CPAP is preferred over mechanical ventilation when possible.
Safety of neuraminidase inhibitors in pregnant and breastfeeding women tanaka...
Safety of neuraminidase inhibitors in pregnant and breastfeeding women tanaka...Ruth Vargas Gonzales
1) A new strain of influenza A virus (H1N1) emerged and spread rapidly globally, increasing concern as it disproportionately affected young people. Pregnant women are also at high risk.
2) The antiviral drugs oseltamivir and zanamivir are effective against the new H1N1 strain. Limited data suggests oseltamivir is unlikely to cause major birth defects, while even less is known about zanamivir's safety during pregnancy.
3) Both drugs are considered compatible with breastfeeding as levels transferred to breastmilk would be low. Continued breastfeeding is recommended even if the mother is being treated.ROP prevention at NICU.pptx
Overall care of newborn should be improved to prevent Retinopathy of Prematurity (ROP). Timely screening is very important to prevent blindness.
Prophylactic Aminophylline for Prevention of Apnea at Higher-Risk Preterm Neo...
Prophylactic Aminophylline for Prevention of Apnea at Higher-Risk Preterm Neo...amir mohammad Armanian
1. The study assessed the prophylactic effects of aminophylline on apnea in preterm neonates with a gestational age less than 32 weeks and/or birth weight less than 1200g.
2. 52 neonates were randomly assigned to receive either aminophylline (group A) or no aminophylline (group C) for the first 10 days.
3. Primary outcomes like apnea, bradycardia and cyanosis were significantly lower in the aminophylline group compared to the control group. Secondary outcomes like need for CPAP and length of hospital stay were also lower in the aminophylline group.Respiratory Failure in the Pregnant Patient
Lecture presented by Dr Mohamed Khaled at the Egyptian African Critical Care Summit 2017 held at Cairo, Egypt
Dizdar et al., 2011
This study compared the efficacy of two animal-derived surfactants, poractant alfa and beractant, in treating respiratory distress syndrome (RDS) in preterm infants. The study found that infants treated with poractant alfa required significantly less oxygen in the first 5 days after treatment compared to those treated with beractant. Infants in the poractant alfa group also had higher rates of extubation within 3 days. Additionally, poractant alfa treatment resulted in fewer infants requiring multiple doses of surfactant compared to beractant treatment. While mortality and other outcomes were similar between groups, survival without bronchopulmonary dysplasia at the end of the study period was significantly higher
seminar on bronco pulmonary dysplasia
This document provides an outline for a presentation on bronchopulmonary dysplasia (BPD). It begins with an introduction defining BPD and its increasing prevalence in preterm infants. The outline then covers the definition, epidemiology, risk factors including prematurity, lung injury from mechanical ventilation and oxygen toxicity, pathophysiology involving disrupted lung development, clinical presentation with respiratory symptoms, and management approaches to prevent and treat BPD.
Neonatal sepsis
Neonatal sepsis occurs when pathogenic organisms enter the bloodstream of newborns, potentially causing infections like septicemia, pneumonia, or meningitis. Worldwide it accounts for 15% of neonatal deaths. In Nepal, neonatal sepsis causes 47.7% of neonatal deaths. It can be early onset within 3 days of life due to maternal infections, or late onset after 3 days from hospital-acquired infections. Common causes are E. coli, Staphylococcus aureus, and Klebsiella. Risk factors include prematurity, low birth weight, maternal infections, and lack of breastfeeding. Symptoms include pallor, apnea, bulging fontanel, and poor feeding. Diagnosis involves sepsis
Similar to Tanl power point (20)
Taquipnea transitoria del recién nacido: Que hay de nuevo?
Taquipnea transitoria del recién nacido: Que hay de nuevo?
Pregnancy in Dermatomyositis Complicated with Covid
Pregnancy in Dermatomyositis Complicated with Covid
Bronchopulmonary dysplasia updates_and_prevention dr falakha
Bronchopulmonary dysplasia updates_and_prevention dr falakha
Safety of neuraminidase inhibitors in pregnant and breastfeeding women tanaka...
Safety of neuraminidase inhibitors in pregnant and breastfeeding women tanaka...
Prophylactic Aminophylline for Prevention of Apnea at Higher-Risk Preterm Neo...
Prophylactic Aminophylline for Prevention of Apnea at Higher-Risk Preterm Neo...
More from zawhtet1984
Yehlaingbwar
This document discusses prognostic factors in epithelial ovarian cancer. It analyzes data from 55 patients treated with primary surgery and chemotherapy between 2005-2009. The key findings are:
1. Significant prognostic factors in univariate analysis included age, histology, FIGO stage, and ascites.
2. Patients aged 70 or older and with FIGO stage IV cancer had poorer prognoses, with a 31-month survival time. Patients with endometrioid or clear cell histology had longer survival, at 51 months.
3. Subgroups like endometrioid/clear cell histology, FIGO stage II, and those with ascites were also significant prognostic factors in univariate analysis.
Kyaw thura zaw
1) The document compares poly-chemotherapy (CVD regimen) and the same chemotherapy (CT) plus interferon-α2a in treating metastatic melanoma.
2) It studies 15 patients receiving either CVD alone or CVD plus interferon-α2a and finds the response rate was highest in the combined treatment group, though not significantly.
3) The median survival was 12 months for both groups, with the combined treatment group having a slightly higher average survival time.
Pyae phyo aung's thesis (breast cancer)
This study examined the significance of HER-2 and hormonal receptor status in patients with locally advanced breast cancer treated with neoadjuvant systemic therapy. It found that hormonal receptor status has a significant prognostic effect on both overall survival and progression-free survival. HER-2 receptor status was found to have a significant prognostic effect on overall survival. No significant association was found between receptor status and clinical response to neoadjuvant chemotherapy. The study was limited by its small sample size and retrospective design.
Zaw htet
1) This study analyzed prognostic factors that influence survival in patients with relapsed follicular lymphoma by examining clinical data from 151 patients.
2) Univariate analysis found that factors like older age, poorer performance status, advanced stage, short duration of response to initial therapy, and not achieving complete response were associated with worse survival.
3) Multivariate analysis identified that duration of response to initial therapy and performance status at relapse were the most important predictors of long-term survival, with patients having responses lasting 2+ years or good performance status having longer 5-year survival.
Sithu ko
The document analyzes the frequency and types of congenital heart diseases in newborns admitted to Tuschinskaya Children's Hospital from 2000 to 2009. It found that septal defects were the most common at 95.6% of cases, with atrial septal defects being the most frequent at 80.5%. The median frequency of congenital heart diseases in newborns each year was 4%. Patients were treated medically to address symptoms until they could undergo surgical treatment. A case study of a newborn with atrioventricular septal defect and patent ductus arteriosus requiring intensive care treatment is also described.
Powerpoint presentation by dr sathiha
This study compared the effectiveness of two chemotherapy regimens, BEACOPP and COPP-ABVD, for treating advanced Hodgkin's lymphoma. 49 patients received either BEACOPP (25 patients) or COPP-ABVD (24 patients). The rate of freedom from treatment failure at 5 years was higher for BEACOPP at 76% compared to 69% for COPP-ABVD. Overall survival rates at 5 years were also higher for BEACOPP at 88% versus 83% for COPP-ABVD. While BEACOPP resulted in better tumor control and survival, it also had more acute toxicity including grade 4 leukopenia in some cycles.
Khant zaw aung
This study compared the efficacy and toxicities of gemcitabine/cisplatin combination chemotherapy and paclitexal/carboplatin combination chemotherapy as first-line treatment for 53 patients with stage IIIB or IV non-small cell lung cancer. The study found that gemcitabine/cisplatin combination resulted in better response rates but not statistically significantly so. It also found that gemcitabine/cisplatin combination resulted in more hematological toxicities. Patient demographics were not significantly different between the two treatment arms. The study concluded that platinum-based combinations are effective for non-small cell lung cancer but require proper premedications.
Chan myae htut
The document presents findings from a study comparing CHOP chemotherapy alone versus CHOP plus rituximab in elderly patients with diffuse large B cell lymphoma. The study found that adding rituximab to CHOP chemotherapy significantly increased complete response rates, decreased treatment failure and relapse rates, and improved event-free and overall survival compared to CHOP alone, without significantly increasing toxicity.
Aung thiha soe
Lung cancer is a leading cause of cancer deaths worldwide. This retrospective study analyzed 95 patients with stage III-IV non-small cell lung cancer treated with first-line combination chemotherapy and second-line single-agent chemotherapy. The study found that the gemcitabine, platinum-based chemotherapy, and radiotherapy (GPR) regimen had a higher clinical response rate (21.3%) compared to other regimens. Leucopenia and fatigue were common toxicities for first-line treatment, while diarrhea was common for second-line treatment. The study concluded that while no regimen was statistically significantly better, GPR appeared to be more effective with acceptable toxicity.
Aung myo zaw(nutrition in preterm and congenital hypotrophy)
The document discusses nutrition for preterm and congenitally small infants. It notes that preterm infants have high nutritional needs for optimal growth. Early minimal enteral feeding can provide advantages like faster weight gain and shorter hospital stays compared to parenteral nutrition alone. Breast milk is preferable to preterm formula due to beneficial components, though formula provides more calories, proteins and minerals. The study assessed the effectiveness of different nutrition methods in 30 preterm and small infants, finding that a combination of preterm formula and breast milk was most effective for growth.
Aung citt nyein
This study evaluated the efficacy and toxicity of a complex combination biochemotherapy regimen for 25 patients with advanced metastatic melanoma. A complete response was seen in 2 patients, partial response in 2 patients, and stable disease in 9 patients. The most common toxicities were lethargy, fever, nausea, vomiting, thrombocytopenia, leukopenia, and neutropenia. Doses of vindesine, cisplatin, and IL-2 often had to be reduced due to toxicities. The regimen showed an objective response rate of 16% with an 8% complete response rate, but dose reductions were frequently required due to treatment-related side effects.
More from zawhtet1984 (11)
Aung myo zaw(nutrition in preterm and congenital hypotrophy)
Aung myo zaw(nutrition in preterm and congenital hypotrophy)
Recently uploaded
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...Nguyen Thanh Tu Collection
https://app.box.com/s/y977uz6bpd3af4qsebv7r9b7s21935vdBBR 2024 Summer Sessions Interview Training
Qualitative research interview training by Professor Katrina Pritchard and Dr Helen Williams
clinical examination of hip joint (1).pdf
described clinical examination all orthopeadic conditions .
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
This Dissertation explores the particular circumstances of Mirzapur, a region located in the
core of India. Mirzapur, with its varied terrains and abundant biodiversity, offers an optimal
environment for investigating the changes in vegetation cover dynamics. Our study utilizes
advanced technologies such as GIS (Geographic Information Systems) and Remote sensing to
analyze the transformations that have taken place over the course of a decade.
The complex relationship between human activities and the environment has been the focus
of extensive research and worry. As the global community grapples with swift urbanization,
population expansion, and economic progress, the effects on natural ecosystems are becoming
more evident. A crucial element of this impact is the alteration of vegetation cover, which plays a
significant role in maintaining the ecological equilibrium of our planet.Land serves as the foundation for all human activities and provides the necessary materials for
these activities. As the most crucial natural resource, its utilization by humans results in different
'Land uses,' which are determined by both human activities and the physical characteristics of the
land.
The utilization of land is impacted by human needs and environmental factors. In countries
like India, rapid population growth and the emphasis on extensive resource exploitation can lead
to significant land degradation, adversely affecting the region's land cover.
Therefore, human intervention has significantly influenced land use patterns over many
centuries, evolving its structure over time and space. In the present era, these changes have
accelerated due to factors such as agriculture and urbanization. Information regarding land use and
cover is essential for various planning and management tasks related to the Earth's surface,
providing crucial environmental data for scientific, resource management, policy purposes, and
diverse human activities.
Accurate understanding of land use and cover is imperative for the development planning
of any area. Consequently, a wide range of professionals, including earth system scientists, land
and water managers, and urban planners, are interested in obtaining data on land use and cover
changes, conversion trends, and other related patterns. The spatial dimensions of land use and
cover support policymakers and scientists in making well-informed decisions, as alterations in
these patterns indicate shifts in economic and social conditions. Monitoring such changes with the
help of Advanced technologies like Remote Sensing and Geographic Information Systems is
crucial for coordinated efforts across different administrative levels. Advanced technologies like
Remote Sensing and Geographic Information Systems
9
Changes in vegetation cover refer to variations in the distribution, composition, and overall
structure of plant communities across different temporal and spatial scales. These changes can
occur natural.
The History of Stoke Newington Street Names
Presented at the Stoke Newington Literary Festival on 9th June 2024
www.StokeNewingtonHistory.com
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...National Information Standards Organization (NISO)
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
Denis is a dynamic and results-driven Chief Information Officer (CIO) with a distinguished career spanning information systems analysis and technical project management. With a proven track record of spearheading the design and delivery of cutting-edge Information Management solutions, he has consistently elevated business operations, streamlined reporting functions, and maximized process efficiency.
Certified as an ISO/IEC 27001: Information Security Management Systems (ISMS) Lead Implementer, Data Protection Officer, and Cyber Risks Analyst, Denis brings a heightened focus on data security, privacy, and cyber resilience to every endeavor.
His expertise extends across a diverse spectrum of reporting, database, and web development applications, underpinned by an exceptional grasp of data storage and virtualization technologies. His proficiency in application testing, database administration, and data cleansing ensures seamless execution of complex projects.
What sets Denis apart is his comprehensive understanding of Business and Systems Analysis technologies, honed through involvement in all phases of the Software Development Lifecycle (SDLC). From meticulous requirements gathering to precise analysis, innovative design, rigorous development, thorough testing, and successful implementation, he has consistently delivered exceptional results.
Throughout his career, he has taken on multifaceted roles, from leading technical project management teams to owning solutions that drive operational excellence. His conscientious and proactive approach is unwavering, whether he is working independently or collaboratively within a team. His ability to connect with colleagues on a personal level underscores his commitment to fostering a harmonious and productive workplace environment.
Date: May 29, 2024
Tags: Information Security, ISO/IEC 27001, ISO/IEC 42001, Artificial Intelligence, GDPR
-------------------------------------------------------------------------------
Find out more about ISO training and certification services
Training: ISO/IEC 27001 Information Security Management System - EN | PECB
ISO/IEC 42001 Artificial Intelligence Management System - EN | PECB
General Data Protection Regulation (GDPR) - Training Courses - EN | PECB
Webinars: https://pecb.com/webinars
Article: https://pecb.com/article
-------------------------------------------------------------------------------
For more information about PECB:
Website: https://pecb.com/
LinkedIn: https://www.linkedin.com/company/pecb/
Facebook: https://www.facebook.com/PECBInternational/
Slideshare: http://www.slideshare.net/PECBCERTIFICATION
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
it describes the bony anatomy including the femoral head , acetabulum, labrum . also discusses the capsule , ligaments . muscle that act on the hip joint and the range of motion are outlined. factors affecting hip joint stability and weight transmission through the joint are summarized.
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityAkanksha trivedi rama nursing college kanpur.
Natural birth techniques are various type such as/ water birth , alexender method, hypnosis, bradley method, lamaze method etcThe Diamonds of 2023-2024 in the IGRA collection
A review of the growth of the Israel Genealogy Research Association Database Collection for the last 12 months. Our collection is now passed the 3 million mark and still growing. See which archives have contributed the most. See the different types of records we have, and which years have had records added. You can also see what we have for the future.
Community pharmacy- Social and preventive pharmacy UNIT 5
Covered community pharmacy topic of the subject Social and preventive pharmacy for Diploma and Bachelor of pharmacy
Walmart Business+ and Spark Good for Nonprofits.pdf
"Learn about all the ways Walmart supports nonprofit organizations.
You will hear from Liz Willett, the Head of Nonprofits, and hear about what Walmart is doing to help nonprofits, including Walmart Business and Spark Good. Walmart Business+ is a new offer for nonprofits that offers discounts and also streamlines nonprofits order and expense tracking, saving time and money.
The webinar may also give some examples on how nonprofits can best leverage Walmart Business+.
The event will cover the following::
Walmart Business + (https://business.walmart.com/plus) is a new shopping experience for nonprofits, schools, and local business customers that connects an exclusive online shopping experience to stores. Benefits include free delivery and shipping, a 'Spend Analytics” feature, special discounts, deals and tax-exempt shopping.
Special TechSoup offer for a free 180 days membership, and up to $150 in discounts on eligible orders.
Spark Good (walmart.com/sparkgood) is a charitable platform that enables nonprofits to receive donations directly from customers and associates.
Answers about how you can do more with Walmart!"
How to Manage Your Lost Opportunities in Odoo 17 CRM
Odoo 17 CRM allows us to track why we lose sales opportunities with "Lost Reasons." This helps analyze our sales process and identify areas for improvement. Here's how to configure lost reasons in Odoo 17 CRM
Recently uploaded (20)
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Community pharmacy- Social and preventive pharmacy UNIT 5
Community pharmacy- Social and preventive pharmacy UNIT 5
Walmart Business+ and Spark Good for Nonprofits.pdf
Walmart Business+ and Spark Good for Nonprofits.pdf
How to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRM
Tanl power point
- 5. Percentage of Term and Preterm newborn Total 30 patients: Boys 20(67%) & Girls 10(30%) 5
- 6. Body weight of patients
- 7. Pathologic events in RDS Rosario N. Santos--Chua, et al , UpToDate , 2009.
- 8. Investigation of Respiratory Distress Syndrome in newborn
- 11. 11
- 13. Surfactant therapy Alveofact, Curosurf, Infasurg, Survanta Curosurf Dosage: Intratracheal: Initial: 2.5 mL/kg/dose (200 mg/kg/dose); may repeat 1.25 mL/kg/dose (100 mg/kg/dose); at 12-hour intervals for up to 2 additional doses; maximum total dose: 5 mL/kg. Curosurf It produces rapid improvements in lung oxygenation and compliance that may require immediate reductions in ventilator settings and FiO2.
- 14. Surfactant versus placebo treatment from Liechty EA; et al, July 1991.
- 15. Differences between the percentage of following cases in Newborn’s Department and NICU
- 16. Antibiotic usage for newborn’s 3 diseases in following department *3 diseases are Aspiration pneumonia, Respiratory distress syndrome & Congenital pneumonia. Pt.no= Patient’s number Pt.no Pt.no Pt.no Antibiotics in NICU (N=21) Antibiotics in Newborn Department (N=9) Antibiotics in Newborn department after treated from NICU (N=21) Netilmicin ( Нетилмицин ) 13 Cefotaxime (Клафоран) 8 Ceftriaxone 10 Ceftriaxone ( Роцефин ) 13 Fluconazole 2 Ciprofloxacin 8 Ciprofloxacin ( Ципробай ) 10 Amikacin 1 Fluconazole 7 Vancomycin ( Ванкомицин ) 6 Netilmicin 4 Fluconazole ( Дифлюкан ) 6 Vancomycin 2 Metronidazole (Метрогил) 5 Metronidazole 2 Ceftazidime (Фортум) 4 Ceftazidime 1 Rifampicin (Рифампицин) 3 Imipenem (Имипенем) 1 Amikacin (Амикацин) 3 Imipenem+Cilastatin (Тиенам) 1 Linezolide (Линизолед) 1
- 17. Differences between antibiotics combination in Newborn Department, Newborn Department after treated from NICU and NICU
- 18. Combine antibiotic treatment according to following diseases
- 19. CPAP and Mechanical Ventilation
- 20. Duration of stay in Neonatal Intensive Care Unit and Newborn’s department NICU Newborn’s department duration 20